z-logo
Premium
Disseminated Bacille Calmette‐Guérin infection in a patient with severe combined immunodeficiency caused by JAK3 gene mutation
Author(s) -
Li Meiyun,
Chen Zhuo,
Zhu Yunlu,
Chen Ji
Publication year - 2019
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.13884
Subject(s) - medicine , severe combined immunodeficiency , immunodeficiency , vaccination , mycobacterium bovis , immunology , tuberculosis , primary immunodeficiency , attenuated vaccine , mycobacterium tuberculosis , bcg vaccine , immunity , virology , immune system , gene , pathology , biology , virulence , biochemistry
Bacille Calmette‐Guérin (BCG), a live attenuated vaccine prepared using Mycobacterium bovis , can prevent tuberculosis in children and is routinely administered to infants in China and many other countries. A serious complication following vaccination is disseminated BCG infection. The risk is greatly increased in patients with severe combined immunodeficiency disease (SCID), a syndrome characterized by deficiency of both humoral and cellular immunity. We report a case of disseminated BCG infection in an infant with SCID caused by two novel janus kinase 3 ( JAK3 ) gene mutations.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom